BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 34060676)

  • 1. Safety and danger: Perceptions of the implementation of harm reduction programs in two communities in Nova Scotia, Canada.
    Jackson LA; Dechman M; Mathias H; Gahagan J; Morrison K
    Health Soc Care Community; 2022 Jan; 30(1):360-371. PubMed ID: 34060676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beliefs, attitudes and experiences of virtual overdose monitoring services from the perspectives of people who use substances in Canada: a qualitative study.
    Marshall T; Viste D; Jones S; Kim J; Lee A; Jafri F; Krieg O; Ghosh SM
    Harm Reduct J; 2023 Jun; 20(1):80. PubMed ID: 37355610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moving towards a continuum of safer supply options for people who use drugs: A qualitative study exploring national perspectives on safer supply among professional stakeholders in Canada.
    Foreman-Mackey A; Pauly B; Ivsins A; Urbanoski K; Mansoor M; Bardwell G
    Subst Abuse Treat Prev Policy; 2022 Oct; 17(1):66. PubMed ID: 36209227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What features of drug treatment programs help, or not, with access? a qualitative study of the perspectives of family members and community-based organization staff in Atlantic Canada.
    Mathias H; Jackson LA; Buxton JA; Dubé A; Kiepek N; Martin F; Martin P
    Subst Abuse Treat Prev Policy; 2024 Mar; 19(1):20. PubMed ID: 38520017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expanding conceptualizations of harm reduction: results from a qualitative community-based participatory research study with people who inject drugs.
    Boucher LM; Marshall Z; Martin A; Larose-Hébert K; Flynn JV; Lalonde C; Pineau D; Bigelow J; Rose T; Chase R; Boyd R; Tyndall M; Kendall C
    Harm Reduct J; 2017 May; 14(1):18. PubMed ID: 28494774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementing harm reduction in non-urban communities affected by opioids and polysubstance use: A qualitative study exploring challenges and mitigating strategies.
    Childs E; Biello KB; Valente PK; Salhaney P; Biancarelli DL; Olson J; Earlywine JJ; Marshall BDL; Bazzi AR
    Int J Drug Policy; 2021 Apr; 90():103080. PubMed ID: 33340947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining respondent-driven sampling with a community-based participatory action study of people who smoke drugs in two cities in British Columbia, Canada.
    Elkhalifa S; Jozaghi E; Marsh S; Thomson E; Gregg D; Buxton J; Jolly A
    Harm Reduct J; 2021 Mar; 18(1):37. PubMed ID: 33771164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Women who use drugs: engagement in practices of harm reduction care.
    Austin T; Lavalley J; Parusel S; Collins AB; Olding M; Boyd J
    Harm Reduct J; 2023 Apr; 20(1):49. PubMed ID: 37055805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uptake, benefits of and barriers to safer crack use kit (SCUK) distribution programmes in Victoria, Canada--a qualitative exploration.
    Ivsins A; Roth E; Nakamura N; Krajden M; Fischer B
    Int J Drug Policy; 2011 Jul; 22(4):292-300. PubMed ID: 21700443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bridging the Gap in Harm Reduction Using Mobile Overdose Response Services (MORS) in the Context of the COVID-19 Pandemic: A Qualitative Study.
    Seo B; Rioux W; Rider N; Teare A; Jones S; Taplay P; Ghosh SM
    J Urban Health; 2024 Apr; 101(2):252-261. PubMed ID: 38514599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding the barriers and facilitators to implementing and sustaining Mobile Overdose Response Services from the perspective of Canadian key interest groups: a qualitative study.
    Seo B; Rider N; Rioux W; Teare A; Jones S; Taplay P; Monty Ghosh S
    Harm Reduct J; 2024 Feb; 21(1):28. PubMed ID: 38308262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Social network support and harm reduction activities in a peer researcher-led pilot study, British Columbia, Canada.
    Elkhalifa S; Jozaghi E; Marsh S; Thomson E; Gregg D; Buxton J; Jolly A
    Harm Reduct J; 2020 Aug; 17(1):57. PubMed ID: 32825836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of a participatory needs assessment demonstrate an opportunity to involve people who use alcohol in drug user activism and harm reduction.
    Crabtree A; Latham N; Bird L; Buxton J
    Harm Reduct J; 2016 Dec; 13(1):37. PubMed ID: 27938376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is needed for implementing drug checking services in the context of the overdose crisis? A qualitative study to explore perspectives of potential service users.
    Wallace B; van Roode T; Pagan F; Phillips P; Wagner H; Calder S; Aasen J; Pauly B; Hore D
    Harm Reduct J; 2020 May; 17(1):29. PubMed ID: 32398090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of syringe decriminalization within the Pennsylvania harm reduction community.
    Lepore M; Hessler J; Mitchell A; Kameg B; Howe R; Cassidy C; Germack H
    Arch Psychiatr Nurs; 2023 Oct; 46():26-32. PubMed ID: 37813500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organizational support for frontline harm reduction and systems navigation work among workers with living and lived experience: qualitative findings from British Columbia, Canada.
    Greer A; Buxton JA; Pauly B; Bungay V
    Harm Reduct J; 2021 Jun; 18(1):60. PubMed ID: 34090473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cross-sectional study of public attitudes towards safer drug use practices in British Columbia, Canada.
    Tzemis D; Campbell J; Kuo M; Buxton JA
    Subst Abuse Treat Prev Policy; 2013 Dec; 8():40. PubMed ID: 24289280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Harm reduction interventions in drug users: current situation and recommendations].
    Bosque-Prous M; Brugal MT
    Gac Sanit; 2016 Nov; 30 Suppl 1():99-105. PubMed ID: 27837802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Practices of care among people who buy, use, and sell drugs in community settings.
    Kolla G; Strike C
    Harm Reduct J; 2020 May; 17(1):27. PubMed ID: 32381011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The postnatal experiences of resettled Syrian refugee women: Access to healthcare and social support in Nova Scotia, Canada.
    Stirling Cameron E; Aston M; Ramos H; Kuri M; Jackson L
    Midwifery; 2022 Jan; 104():103171. PubMed ID: 34736018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.